Home » Newsletters » BioWorld Asia

BioWorld Asia

April 1, 1998

View Archived Issues

TAb Attempting To Bolster Finances With £20M Offering

Role Of Cytotoxic T Cells Discovered In Controlling HIV

French Officials Back Formation Of Biotechnology Seed Fund

Europe Considering Guidelines For Gene Therapy Products

D-Pharm Receives Patent In US For Epilepsy Drug

Phytopharm Seeks Partners For Eczema Botanical Product

Transgène Sells More Shares At Higher Price Than Expected

Ribotargets, MSI In Pact For RNA-Based Drug Design

Wealthy Australian Wants To Back Human Cloning Efforts

Australian Researchers Discover Key Malaria Gene

French Scientists Develop More Accurate Gene Therapy Targeting

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.